Green Biologics announces Dr. Tim Davies as President of the Society for Industrial Microbiology and Biotechnology.
29th April 2013
Abingdon, Oxfordshire U.K. (April 15, 2013) – Green Biologics Limited (GBL), a UK based industrial biotechnology company announces the election of Dr. Tim Davies, GBL’s Chief Technology Officer, as President of the Society for Industrial Microbiologyand Biotechnology. Dr. Davies has been a director of SIMB since 2010.
The Society for Industrial Microbiology and Biotechnology is a non-profit, internationalassociation dedicated to the advancement of microbiological sciences, especially as they apply to industrial products, biotechnology, materials, and processes. Founded in1949, SIMB promotes the exchange of scientific information through its meetings andpublications, and serves as liaison among the specialized fields of microbiology. Membership in the Society is extended to all scientists and companies in the generalfield of microbiology.
Dr. Davies joined GBL as Chief Technology Officer in 2011 after having served as aboard advisor since 2004. “I’m personally delighted that Tim’s vision and leadershipskills have been recognized by SIMB and have no doubt of his ability to guide and leadthis outstanding organization,” said Sean Sutcliffe, Chief Executive of GBL. “Thesequalities have been long recognized by those of us who have worked so closely with Timover these past critical years of growth at Green Biologics.” Dr. Davies will act as President elect from August 2013 and will begin his term as President of SIMB in August, 2014 serving through 2015 and will continue to serve on the SIMB board as Past-President through 2016.
About Green Biologics
GBL is a privately held industrial biotechnology company based in Abingdon,Oxfordshire, UK specializing in the manufacture of renewable chemicals and advancedbiofuels. The company’s core focus is n-butanol, a chemical precursor for paints,coatings, adhesives, inks, plastics, pharmaceuticals, household cleaners and personalcare ingredients with a 4.5 million tonne global market worth $10 billion. GBL is the global technology leader in renewable n-butanol and has developed advancedfermentation technology to produce renewable chemicals from non-edible cellulosicfeedstocks such as agricultural and forestry residuals and municipal solid wastes. GBLhas laboratory and production facilities in the U.K. and the U.S. and operates globally inEurope, China, North America, India and Brazil.
For more information please visit www.greenbiologics.com.
Green Biologics Limited
Samantha Jeskins - +44 1235 435710
- 8th August 2016
Silicon photonics pioneer looks to ease the data centre networking problem
- 1st August 2016
How green is my data centre?
- 29th July 2016
Next Generation Data Centre Networking
- 7th April 2016
Green Biologics Selects Nexeo Solutions as its U.S. Distribution Partner
- 3rd March 2016
Green Biologics Partners with Acme Hardesty
- 11th February 2016
Andrew Rickman to present ‘The disruptor’s view’ at TM&A Europe
- 29th January 2016
Green Biologics Named in the 2015 Global Cleantech 100
- 2nd December 2015
Green Biologics Starts Construction in Little Falls, MN
- 9th November 2015
The American Chemistry Council Approves Membership for Green Biologics
- 5th October 2015
The Future of the Data Center: Reinventing the Network
- 14th September 2015
Rockley Photonics demonstrates breakthrough technology
- 15th June 2015
ButaNext: Innovating to Create a More Effective Generation of Biofuels